1468P Patients’ perspective on tolerability of dostarlimab in NSCLC: Patient-reported outcomes from the phase II PERLA trial von Reck, M., Ortega Granados, A.L.O., de Marinis, F., Shen, Q., Boklage, S.H., Dabrowski, C., Cho, L., Meyers, O.

Volltext

215 Adherence with TOBI® among cystic fibrosis patients with Pseudomonas aeruginosa infection von Joish, V.N, Sansgiry, S.S, Boklage, S.H, Chopra, P.A, Sethi, S

Volltext

569P Mismatch repair deficient, stage II/III rectal cancer: Real-world patient, tumour, and treatment characteristics in the Netherlands von Lunenberg, R.A., Franken, I.A., van der Baan, F.H., Sijtsma, F.P.C., Vink, G., Koopman, M., Intven, M., Braat, M.N.G.J.A., Moons, L., Laclé, M., Elferink, M., Boklage, S.H., Garside, J., Wuijtswinkel, R.V., Roodhart, J.M.L.

Volltext